Worm therapy for hay fever? More research is needed
April 18, 2012 By Katherine Kahn in Diseases, Conditions, Syndromes
Purposely infecting patients with hookworms or whipworms to treat hay fever and other immune-related diseases has been experimented with since the 1970s. A new review by The Cochrane Library concludes that current evidence doesnt yet support the use of this therapy. However, worm therapy does appear to be safe, the reviews lead author says.
Allergic diseases affect hundreds of millions of people worldwide, especially in industrialized countries, says review author Ashley Croft, M.D., a public health physician at the headquarters of the Surgeon General, Whittington Barracks, in Lichfield, UK. Existing treatments for allergies, which mostly involve pharmacotherapy, are often expensive, dangerous, or ineffective. If worm therapy can be shown to be effective and safe, it will represent an important new clinical option for treatment.
Croft theorizes that worm therapy might work if having intestinal worms tones up the immune system of their human hosts, so that the host stops being over-responsive to common allergens. This helps the worms avoid detection and destruction by the hosts immune system.
Joel Weinstock, M.D., chief of gastroenterology at Tufts University Medical Center in Boston, is one of the few researchers in the United States investigating the use of worm therapy in immune-related diseases.
Its generally appreciated that in the 20th century a whole series of immunological diseases have emerged out of nowhere, Weinstock explains, including hay fever, asthma, inflammatory bowel diseases, and multiple sclerosis. Why did these diseases emerge? If you look around the world, these diseases are fairly common in industrialized countries, but in less developed countries, they are relatively rare.
The cause, Weinstock believes, is the tremendous improvement in hygieneand that includes lack of exposure to intestinal worms, such as hookworms and whipworms. Up until the 20th century, everybody had worms, Weinstock says.
The lack of worm infections in modern societies, Weinstock conjectures, has led to over-reactive immune systems and an increase in immune-related diseases.
Crofts review examined evidence from two placebo-controlled, double blinded studies that enrolled a total of 130 adults who had either intermittent or persistent allergic rhinitis. One study used hookworm larvae, which enter through the skin and travel to the intestines and the other study used pig whipworm eggs that participants swallowed. Participants who used worm therapy had no reduction in hay fever symptoms or percentage of days when symptoms were minimal. They also had no changes in lung function or quality of life scores.
Croft cautions that these studies are too small to truly evaluate effectiveness. It did come as a surprise, therefore, that we found that people with allergic rhinitis who took worms were less likely to have to take tablets as rescue medication during the grass pollen season.
Weinstock also says that the studies to date havent been designed very well and says it was surprising researchers found any response at all since the study follow-up times were too short. To treat an allergy, you probably have to have a treatment strategy thats at least six months long, before evaluating effectiveness, he says. The studies ran for only three months and six months, respectively, after initiating worm therapy.
Our main finding was that worm therapy is safe, says Croft. In participants who took worms there were some gastrointestinal side effects, such as abdominal pain and diarrhea, but these were transient and were not so severe as to cause people to drop out of the trials.
Croft says that there is enough evidence to support continued research in worm therapy. Clinical trials in worm therapy are not expensive to run and the potential benefits from this new form of therapy are very great, he says.
More information: Croft A.M., Bager P., Kumar S. Helminth therapy (worms) for allergic rhinitis. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD009238. DOI: 10.1002/14651858.CD009238.pub2
Provided by
Health Behavior News Service
-
Researchers discover how worms promote healing
Dec 01, 2010 |
not rated yet |
0
-
Childhood eczema and hay fever leads to adult allergic asthma
Apr 15, 2011 |
not rated yet |
0
-
Therapeutic effect of worm-derived proteins on experimental colitis
Mar 04, 2010 |
not rated yet |
0
-
Potential gene therapy for patients with rare disease
Apr 12, 2012 |
not rated yet |
0
-
Kids born with HIV growing up well
Apr 21, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Swine flu pandemic of 2009 more deadly for younger adults, study finds
As the world prepares for what may be the next pandemic strain of influenza virus, in the H7N9 bird flu, a new UC Irvine study reveals that the 2009 H1N1 swine flu pandemic was deadliest for people under the age of 65, while ...
Diseases, Conditions, Syndromes
18 hours ago |
not rated yet |
0
Polio cases found in Kenya and Somalia, WHO says
The World Health Organization says the Horn of Africa is experiencing an outbreak of polio with cases confirmed in Kenya and Somalia.
Diseases, Conditions, Syndromes
18 hours ago |
not rated yet |
0
SARS-like virus claims new life in Saudi
A man who had contracted the coronavirus has died in Saudi Arabia, raising the death toll in the kingdom from the SARS-like virus to 17, the health ministry announced on its website on Wednesday.
Diseases, Conditions, Syndromes
18 hours ago |
not rated yet |
0
Novel approach for influenza vaccination shows promise in early animal testing
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
Diseases, Conditions, Syndromes
19 hours ago |
not rated yet |
0
|
Mild hypothyroidism raises mortality risk among heart failure patients
Patients with underlying heart failure are more likely to experience adverse outcomes from mild hypothyroidism, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & ...
Diseases, Conditions, Syndromes
21 hours ago |
not rated yet |
0
Major human drug trial underway for Alzheimer's
A potentially ground-breaking human drug trial is currently underway, which aims to discover whether blood pressure medication can slow or halt the progression of Alzheimer's Disease (AD). This is the latest ...
Pay attention: How we focus and concentrate
Scientists at Newcastle University have shed new light on how the brain tunes in to relevant information.
New discovery in fight against deadly meningococcal disease
Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, was part of an international team that discovered the previously unknown pathway of how the bacterium colonizes people.
Are kids who take music lessons different from other kids?
(Medical Xpress)—Research by U of T Mississauga psychology professor Glenn Schellenberg reveals that two key personality traits – openness-to-experience and conscientiousness—predict better than IQ ...
Study reveals active site of enzyme linked to stuttering
(Medical Xpress)—Scientists from the Joint Center for Structural Genomics (JCSG) at SLAC National Accelerator Laboratory have determined the 3-D structure of the chemically active part of an enzyme involved ...
Researchers identify networks of neurons in the brain that are disrupted in psychiatric disease
Studying the networks of connections in the brains of people affected by schizophrenia, bipolar disease or depression has allowed Dr. Peter Williamson, from Western University, to gain a better understanding of the biological ...